How Neural Stem Cells Promote the Repair of Brain Injury Through Immunoregulation

How Neural Stem Cells Promote the Repair of Brain Injury Through Immunoregulation

Brain injuries, including traumatic brain injury and stroke, are leading causes of death and long-term disability worldwide. Inflammation plays a critical role in secondary injury following brain trauma. Neural stem cells (NSCs), known for their self-renewal and pluripotency, were initially thought to promote tissue repair through direct cell replacement. However, recent research has shifted focus to their bystander effects, which include immunomodulation, neurotrophic support, and reparative functions. Despite these advances, the specific mechanisms by which NSCs exert their immunomodulatory effects remain poorly understood. This article explores the immunoregulatory roles of NSCs, focusing on their interactions with microglia, systemic immune responses, and the molecular pathways involved.

CD200-CD200R Axis in Microglia Regulation

CD200, a member of the immunoglobulin superfamily, is expressed on immune cells such as T and B cells, as well as on NSCs. The interaction between CD200 and its receptor CD200R on microglia helps maintain microglia in a resting state. In CD200-deficient mice, microglia exhibit heightened responses to inflammatory stimuli, including Toll-like receptor agonists and interferon-gamma, suggesting that CD200 enhances synaptic plasticity and suppresses microglial activation. Activation of CD200R with CD200 fusion protein reduces the expression of microglial activation markers like CD40. Co-culture experiments have shown that NSCs overexpress CD200, while microglia overexpress CD200R, indicating a significant interaction between these cells. Interleukin-4 (IL-4) may play a crucial role in this process. These findings suggest that NSCs help maintain microglia in a resting state through the CD200-CD200R axis.

CX3CL1-CX3CR1 Axis in Microglia Inhibition

CX3CL1, a cytokine primarily expressed in NSCs and neurons, exists in both membrane-bound and soluble forms. It binds to CX3CR1, a receptor exclusively expressed by microglia in the brain. During excitotoxicity or inflammatory injury, the secretion of soluble CX3CL1 increases, inhibiting microglial activation. Disruption of the CX3CL1-CX3CR1 axis leads to increased secretion of pro-inflammatory cytokines such as IL-1-beta, TNF-alpha, IL-6, and interferon-gamma. In pathological conditions, decreased CX3CL1 levels result in microglial activation. NSCs may secrete CX3CL1, which interacts with CX3CR1 on microglia to inhibit the production of inducible nitric oxide synthase, IL-1, TNF-alpha, and IL-6, thereby promoting brain tissue repair.

NLRP3 Inflammasome Regulation by NSCs

The NLRP3 inflammasome regulates caspase-1 activation, promoting the maturation and secretion of pro-IL-1-beta and pro-IL-18, and inducing pyroptosis, a form of inflammatory cell death. Inhibition of the NLRP3 pathway with MCC950, a specific NLRP3 inhibitor, alleviates behavioral deficits and inflammatory injuries in brain injury models. NSC transplantation reduces the expression of NLRP3 inflammasome, caspase-1, and IL-1-beta in microglia, preventing the release of neurotoxic inflammatory factors. Additionally, NSCs inhibit microglial pyroptosis and promote phagocytosis by surviving activated microglia, which may be linked to decreased NLRP3 activation.

NSC-Derived Exosomes in Neuroprotection

Exosomes, membrane-bound nanovesicles involved in cell-to-cell communication, contain proteins, lipids, microRNAs, and messenger RNAs. NSC-derived exosomes (NSC-Exos) have been shown to promote neuroprotection in stroke models. NSC-Exos reduce neuronal apoptosis, microglial activation, and neuroinflammation. Specifically, miR-26b-5p enriched in NSC-Exos alleviates nerve injury after cerebral ischemia/reperfusion by suppressing microglial activation.

Microglia Phenotypic Polarization by NSCs

Microglia can polarize into a pro-inflammatory M1 state or an anti-inflammatory M2 state. Co-culture of microglia and NSCs reduces the number of M1 microglia and increases M2 microglia. In a mouse model of closed craniocerebral injury, NSC transplantation decreased levels of ED1 and TNF-alpha-positive microglia while increasing insulin growth factor-1-positive microglia. The CXCL12-CXCR4 axis and other signaling pathways may play roles in this regulatory process.

Systemic Immune Response Regulation by NSCs

NSCs also regulate systemic immune responses. Intravenous transplantation of NSCs reduces pro-inflammatory factors in the ischemic cerebral hemisphere and blood while increasing anti-inflammatory factors such as TGF-beta and IL-10. NSCs accumulate in the spleen, blocking its contraction and suppressing peripheral immune responses. This systemic immunomodulation contributes to reduced leukocyte infiltration and better brain tissue repair.

Matrix Metalloproteinase-9 (MMP-9) and Blood-Brain Barrier Integrity

MMP-9, a member of the metzincin family, is involved in brain physiology and pathology, including excitotoxicity, neuronal damage, apoptosis, oxidative stress, and blood-brain barrier (BBB) disruption. Overexpression of MMP-9 increases BBB permeability by degrading tight junction proteins. NSC transplantation reduces MMP-9 expression, alleviating microvascular inflammation and BBB damage. This effect may be mediated by adenosine monophosphate-activated protein kinase-dependent downregulation of ICAM-1, reducing neutrophil infiltration and inflammatory cytokine release.

Conclusion

NSCs play a pivotal role in promoting brain injury repair through immunoregulation. Their interactions with microglia via the CD200-CD200R and CX3CL1-CX3CR1 axes, regulation of the NLRP3 inflammasome, and secretion of exosomes contribute to neuroprotection and tissue repair. Additionally, NSCs modulate systemic immune responses and maintain BBB integrity by inhibiting MMP-9. While further research is needed to fully understand the biological roles of NSCs in immunoregulation, their therapeutic potential is increasingly evident. NSC-based therapies offer promising avenues for the treatment of brain injuries, potentially bringing new hope for patients with these devastating conditions.

doi.org/10.1097/CM9.0000000000001039

Was this helpful?

0 / 0